Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay

Stock Information for Precipio Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Precipio Inc.

Precipio Announces Q4 and year-end 2025 Shareholder Update Call
Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year
Precipio Takes Major Steps Toward a Clean Balance Sheet
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting
Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact
Precipio Announces its Q3-2025 Financial Results
Precipio Announces Q3-2025 Shareholder Update Call
Precipio Terminates Its ATM

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.